Yeruusaalem, 13 Janaayo, 2026 (TPS-IL) — shirkadda tiknoolajiyada bayoolojiga ee fadhigeedu yahay Xayfaa, MeMed, ayaa lagu abaalmariyey deeq dhan $2 milyan oo doolar oo ka timid Hay’adda Hal-abuurka Israa’iil si loo dhiso kaydka bayoolojiga ee ugu horreeya dalka ee baaritaanka degdegga ah iyo proteomics. Hindisahan ayaa dardargelin doona horumarinta qalabka baaritaanka ee awoodda AI-u-leeyahay ee bukaanada halista sare leh iyadoo la isku darayo muunado bayooloji iyo xogta daaweynta iyo qaab-dhismeedka difaaca jirka.
Kaydka bayoolojiga ee MeMed ayaa looga gol leeyahay in wax looga qabto cilladaha muhiimka ah ee daawada degdegga ah, halkaas oo dhakhaatiirtu ay wajahayaan go’aamo halis ah iyagoo aan haysan faham bayooloji oo dhab ah. Tijaabada MeMed BV ee shirkadda ayaa horay u heshay oggolaansho FDA ah si loo kala saaro caabuqyada bakteeriyada iyo kuwa fayrasyada ah 15 daqiiqo gudahood, halka qalabkeeda MeMed Severity uu helay magacaabista FDA Breakthrough Device si loo saadaaliyo natiijooyinka daran ee caabuqyada degdegga ah.